Generics BulletinHBW InsightIn VivoMedtech InsightPink SheetScrip

Generics Bulletin

Medtech Insight

FDA Warns Apotex Management To Demand Quality, Meet Specs

17 Aug 2018

• By Bowman Cox

Vintage inscription made by old typewriter, warning

Related Content

Manufacturing Compliance Updates In Brief: A Reduced Focus On Data Integrity

06 Apr 2018

FDA Resumes Quality Metrics Effort With Feedback And Site Visit Initiatives

28 Jun 2018

Manufacturing Compliance Updates In Brief From US FDA And EU

30 Jun 2018

The Baxter/Claris Warning Letter: Out Of Spec, Out Of Mind

24 Jul 2018

Fresenius Kabi Hit With Two Warning Letters At Sites In India In December

03 Jan 2018

FDA Cites Lupin For Poor Quality Metric Performance

30 Jun 2017

FDA’s Revised Quality Metrics Program: Voluntary Now, Mandatory Later

28 Nov 2016

Related Companies

Apotex Inc.

Additional Topics

United States India Asia Pacific Manufacturing Quality Compliance BioPharmaceutical

More from Manufacturing

More from Compliance

Twitter feed RSS feed RSS feed

About UsOpens in new window
Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us
Customer Service
Subscribe
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window

Copyright © 2025 Pharma Intelligence UK Limited (Citeline), a Norstella company Pharma Intelligence UK Limited is a company registered in England and Wales with company number 13787459 whose registered.